April 30, 2012
BEDFORD, Mass. and SAN DIEGO,-- Hologic, Inc. (NASDAQ: HOLX) and Gen-Probe Incorporated (NASDAQ: GPRO) today announced that their Boards of Directors have unanimously approved a definitive agreement under which Hologic will acquire all of the outstanding shares of Gen-Probe for $82.75 per share in cash, or a total enterprise value of approximately $3.7 billion. The [...]
April 30, 2012
LAKE FOREST, Ill -- IDEX Corporation (NYSE: IEX) announced today that it has acquired ERC from MH Capital Partners II, L.P. (“MH Capital”). ERC is a leader in the manufacture of gas liquid separations and detection solutions for the life science, analytical instrumentation and clinical chemistry markets. ERC’s pioneering products include in-line membrane vacuum degassing [...]
April 30, 2012
Despite deep experience and heavy investment in their manufacturing and quality control processes, Nidar were unable to identify the cause of the problem which resulted in significant waste, downtime, energy usage and re-work costs. Because chocolate manufacturing is a complex process with many variables, Nidar required more powerful analytical tools than traditional Statistical Process Control [...]
April 30, 2012
Germantown, MD, and Hilden, Germany,— QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that Cardinal Health (NYSE: CAH) has extended its portfolio of laboratory offerings to select U.S. hospitals to include QIAGEN automated laboratory systems and test kits for molecular diagnostics. Cardinal Health, a leading health care services company, will distribute QIAGEN’s molecular [...]
Eureka Genomics Launches a Novel Custom Genotyping Service
April 30, 2012
HERCULES, CA, April 30, 2012. Eureka Genomics (EG) has launched a custom service for the detection of a moderate number of markers in a large sample number of samples; a low cost, low density marker assay (LDMA). This platform addresses the gap between traditional array technologies and multiplex PCR and is designed for the customized [...]
m2p-labs launches a new media preparation robot
April 30, 2012
Baesweiler/Aachen – m2p-labs sets a new standard in culture media development and launches a new, exceptionally compact pipetting robot on the market. The new device ´RoboLector®S´ will be presented for the first time at the Interphex trade show in New York from the 1st-3rd May 2012 at the m2p-labs booth 3573. The optimal selection of [...]
World’s Smallest Piezo Micromanipulator
April 30, 2012
Warner Instruments is pleased to introduce the Sensapex, a NEW 3D Piezo Movement Micromanipulator. This manipulator is a compact and has a full featured controller designed for high precision positioning to maximize your electrophysiological research. • Penetration mode provides high acceleration steps for cell insertion • 20 mm of travel in all axes • Compact, [...]
BioHealth Innovation, Inc. Appoints Qiagen’s Douglas Liu to Board of Directors
April 30, 2012
ROCKVILLE, Md., -- BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the appointment of Douglas Liu, Senior Vice President of Global Operations at Qiagen, to its Board of Directors. "Doug is an outstanding addition to our board," said [...]
Vermillion Resolves Non-Contingent Claims with Bio-Rad
April 30, 2012
AUSTIN, Texas, -- Vermillion, Inc. (NASDAQ:VRML), a leading molecular diagnostics company, has resolved all four of the non-contingent contract claims with Bio-Rad Laboratories, Inc. arising from the sale to Bio-Rad of Vermillion's protein research tools and collaborative services business in November 2006. In exchange for a final settlement of the non-contingent claims, Bio-Rad will receive [...]
Alan Schafer to head Population Genetics
April 30, 2012
Alan Schafer to head Population Genetics. Cambridge, UK – Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has appointed Alan Schafer, PhD to the post of Chief Executive Officer. Schafer brings deep experience in research, “big pharma” management and building new businesses. He is Adjunct Professor of Innovation at [...]
